Literature DB >> 1951266

Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile.

C Ferreccio1, V Prado, A Ojeda, M Cayyazo, P Abrego, L Guers, M M Levine.   

Abstract

To prepare a field site for evaluating preventive interventions against endemic shigellosis, the authors followed prospectively a cohort of 360 children (90 each of children aged 0-11, 12-23, 24-35, and 36-47 months) in Santa Julia, a low socioeconomic area in Santiago, Chile, from November 1986 through April 1989 with twice weekly household visits for diarrheal disease; infants replaced children who reached 60 months of age. Coprocultures on 2 consecutive days from children with diarrhea and from age-matched controls within the cohort were cultured for Shigella. Bacteriologic surveillance was also maintained in the health center and children's hospital serving Santa Julia. In this community, where all households had access to potable water (68% inside) and all but 3% had access to a toilet, but where there was marked crowding, the overall incidence of diarrheal disease in the cohort was low (2.26 episodes/12 child months of observation in children aged 0-11 months and 2.09 in those aged 12-23 months), yet Shigella infections were common. Shigella accounted for 10% of diarrheal episodes in the cohort (vs. 3.2% isolation rate in controls, p less than 0.0001). The incidence of shigellosis in children aged 12-47 months was 0.16 cases per 12 child months of observation; in the first 5 years of life, a child had a 67% chance of experiencing shigellosis. Shigella sonnei, Shigella flexneri 2a, and S. flexneri 6 caused greater than 79% of the infections. Shigella occurred more often in hospitalized cases of diarrhea than in age-matched cases detected in the health center or by household surveillance (p less than 0.0001). An initial episode of Shigella diarrhea did not diminish overall the risk of subsequent shigellosis but did confer 72% protection (p = 0.05) against illness due to the homologous serotype. The high rate of both S. sonnei and S. flexneri shigellosis in a population with a low background rate of diarrhea makes Santa Julia an appropriate site for assessing the efficacy and effectiveness of measures to reduce Shigella infections.

Entities:  

Keywords:  Age Factors; Americas; Bacterial And Fungal Diseases--transmission; Biology; Child; Child Health Services; Chile; Cohort Analysis; Communication; Control Groups; Delivery Of Health Care; Demographic Factors; Developing Countries; Diarrhea; Diarrhea, Infantile; Diseases; Economic Factors; Epidemiologic Methods; Examinations And Diagnoses; Health; Health Services; Home Visits; Immunity; Infections; Laboratory Examinations And Diagnoses; Latin America; Low Income Population; Maternal-child Health Services; Measurement; Physiology; Population; Population Characteristics; Population Dynamics; Prevalence; Primary Health Care; Prospective Studies; Research Methodology; Sampling Studies; Seasonal Variation; Social Class; Socioeconomic Factors; Socioeconomic Status; South America; Studies; Urban Population; Youth

Mesh:

Year:  1991        PMID: 1951266     DOI: 10.1093/oxfordjournals.aje.a116134

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  79 in total

Review 1.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

Review 2.  Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.

Authors:  Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

3.  Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine.

Authors:  R W Kaminski; M Wu; K R Turbyfill; K Clarkson; B Tai; A L Bourgeois; L L Van De Verg; R I Walker; E V Oaks
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

4.  Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.

Authors:  BreOnna C DeLaine; Tao Wu; Christen L Grassel; Avital Shimanovich; Marcela F Pasetti; Myron M Levine; Eileen M Barry
Journal:  Pathog Dis       Date:  2016-04-21       Impact factor: 3.166

Review 5.  Progress and pitfalls in Shigella vaccine research.

Authors:  Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein; Alessio Fasano; Karen L Kotloff; Myron M Levine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-19       Impact factor: 46.802

Review 6.  The genomic signatures of Shigella evolution, adaptation and geographical spread.

Authors:  Hao Chung The; Duy Pham Thanh; Kathryn E Holt; Nicholas R Thomson; Stephen Baker
Journal:  Nat Rev Microbiol       Date:  2016-02-29       Impact factor: 60.633

7.  A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation.

Authors:  Ha Vinh; Nguyen Thi Khanh Nhu; Tran Vu Thieu Nga; Pham Thanh Duy; James I Campbell; Nguyen Van Minh Hoang; Maciej F Boni; Phan Vu Tra My; Christopher Parry; Tran Thi Thu Nga; Pham Van Minh; Cao Thu Thuy; To Song Diep; Le Thi Phuong; Mai Thu Chinh; Ha Thi Loan; Nguyen Thi Hong Tham; Mai Ngoc Lanh; Bui Li Mong; Vo Thi Cuc Anh; Phan Van Be Bay; Nguyen Van Vinh Chau; Jeremy Farrar; Stephen Baker
Journal:  BMC Infect Dis       Date:  2009-12-15       Impact factor: 3.090

8.  A review of changing episode definitions and their effects on estimates of diarrhoeal morbidity.

Authors:  Jim Wright; Stephen W Gundry; Ronán M Conroy
Journal:  J Health Popul Nutr       Date:  2007-12       Impact factor: 2.000

9.  Increased isolation and characterization of Shigella sonnei obtained from hospitalized children in Tehran, Iran.

Authors:  Reza Ranjbar; Mohammad M Soltan Dallal; Malihe Talebi; Mohammad R Pourshafie
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

10.  Global illness and deaths caused by rotavirus disease in children.

Authors:  Umesh D Parashar; Erik G Hummelman; Joseph S Bresee; Mark A Miller; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.